Dr Reddy's Laboratories (DRREDDY) Stock Price, News & Analysis

Company Overview

Dr. Reddy’s Laboratories is a global pharmaceutical company headquartered in Hyderabad, India, specializing in the development, manufacture and marketing of a broad range of generic medicines, active pharmaceutical ingredients (APIs) and biosimilars. Through its international arm, the company supplies prescription and over-the-counter (OTC) products in key therapeutic areas such as oncology, gastroenterology, pain management, dermatology and cardiovascular health. Its generics portfolio spans oral solids, injectables, liquids and topical dosage forms designed to address healthcare needs in both developed and emerging markets.

Founded in 1984 by visionary entrepreneur Dr. K. Anji Reddy, the company has grown from a domestic API supplier into a diversified biopharma enterprise. Over the decades, it has established manufacturing facilities in India, Russia, the United States and Europe, alongside research centres focusing on formulation development, process engineering, biosimilar innovation and novel drug discovery. Dr. Reddy’s has also formed strategic partnerships with multinational pharmaceutical companies to co-develop and commercialize new therapies.

Under the leadership of Chairman Satish Reddy and Managing Director & CEO G.V. Prasad, Dr. Reddy’s maintains a robust R&D pipeline with programs in oncology, immunology, dermatology and other therapeutic segments. The company’s global workforce of more than 20,000 employees is supported by research sites in Hyderabad, Europe and the U.S., enabling streamlined clinical development and regulatory filings across multiple geographies.

With a commitment to affordability and accessibility, Dr. Reddy’s continues to expand its product registrations in North America, Europe, Latin America, Asia-Pacific and the Commonwealth of Independent States (CIS). Its strategic focus on biosimilars and differentiated formulations seeks to address growing patient demand for high-quality, cost-effective medicines while driving sustainable growth in international markets.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

DRREDDY Stock Analysis - Frequently Asked Questions

How do I buy shares of Dr Reddy's Laboratories?

Shares of DRREDDY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:DRREDDY
• CIK: N/A
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A